Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

XBiotech discovers neutralizing antibodies for Ebola virus

Nov. 11, 2015

Na-GST-1/Alhydrogel hookworm vaccine well tolerated and immunogenic in phase I studies

Nov. 10, 2015

Idenix Pharmaceuticals divulges anti-HCV nucleosides

Nov. 10, 2015

Pivotal phase III trial of RSV-F vaccine in older adults gets started by Novamax

Nov. 10, 2015

RSV vaccine candidate shows promise for children

Nov. 9, 2015

New antimalarial strategy shows promising preclinical results

Nov. 9, 2015

Eisai begins two joint research agreements to develop new antimalarial medicines

Nov. 9, 2015

Global Health Innovative Technology Fund announces grants for infectious disease research

Nov. 9, 2015

FDA grants fast track designation to Paratek's omadacycline for ABSSSI, CABP and cUTI

Nov. 5, 2015

Institut Pasteur Korea and Terramark Markencreation disclose anti-HCV agents

Nov. 5, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...